EXHIBIT 10.9 ------------Share Purchase Agreement • May 27th, 2005 • Sinovac Biotech LTD • Pharmaceutical preparations • British Columbia
Exhibit 10.1 ------------ SECURITIES PURCHASE AGREEMENT -----------------------------Securities Purchase Agreement • January 10th, 2005 • Sinovac Biotech LTD • Pharmaceutical preparations • New York
This Registration Rights Agreement (this "Agreement") is made and entered --------- into as of December 31, 2004, by and among Sinovac Biotech Ltd., a West Indies corporation (the "Company"), and the purchasers signatory hereto (each such -------...Registration Rights Agreement • January 10th, 2005 • Sinovac Biotech LTD • Pharmaceutical preparations
EXHIBIT 10.5 ------------ This is an Exhibit to the Form 20-F of Sinovac Biotech Ltd. ----------------------------------------------------------- Attached find the following materials: Consulting Agreement entered into between the Company...Consulting Agreement • June 30th, 2004 • Sinovac Biotech LTD • Pharmaceutical preparations
ARTICLE I REPRESENTATIONS AND WARRANTIES OF THE SINOVAC SHAREHOLDER --------------------------Share Purchase Agreement • September 26th, 2003 • Net Force Systems Inc • Services-prepackaged software
EXHIBIT B --------- NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM...Security Agreement • January 10th, 2005 • Sinovac Biotech LTD • Pharmaceutical preparations
EXHIBIT 10.3 ------------ This is an Exhibit to the Form 20-F of Sinovac Biotech Ltd. ----------------------------------------------------------- Attached find the following materials: Consulting Agreement entered into between the Company and...Consulting Agreement • June 30th, 2004 • Sinovac Biotech LTD • Pharmaceutical preparations
INDEMNIFICATION AGREEMENTIndemnification Agreement • April 29th, 2019 • Sinovac Biotech LTD • Pharmaceutical preparations • New York
This Indemnification Agreement (this “Agreement”) is entered into as of , by and between Sinovac Biotech Ltd., a company incorporated under the laws of Antigua and Barbuda (the “Company”), and the undersigned, a director and/or an officer of the Company (“Indemnitee”), as applicable.
Cooperation Agreement on the Research and Development of Avian Flu Vaccine -------------------------------------------------------------------------- for Human Use entered into between the Company and --------------------------------------------------...Cooperation Agreement • May 27th, 2005 • Sinovac Biotech LTD • Pharmaceutical preparations
SINOVAC BIOTECH LTD. 10,000,000 Common Shares ($0.001 par value per Share) UNDERWRITING AGREEMENT January 27, 2010Underwriting Agreement • January 28th, 2010 • Sinovac Biotech LTD • Pharmaceutical preparations • New York
CORPORATE SERVICES ------------------ AGREEMENT ---------Corporate Services Agreement • May 27th, 2005 • Sinovac Biotech LTD • Pharmaceutical preparations • Pennsylvania
ANTIGUA AND BARBUDA ------------------- A.D. 2001 ---------Lease Agreement • April 1st, 2002 • Net Force Systems Inc
andDebt to Equity Conversion Agreement • July 17th, 2002 • Net Force Systems Inc • Services-prepackaged software
EXCLUSIVE PROMOTION SERVICE AGREEMENTExclusive Promotion Service Agreement • March 31st, 2008 • Sinovac Biotech LTD • Pharmaceutical preparations
GLAXOSMITHKLINE (China) Investment Co., Ltd., whose registered office is at 9/F, Building A Ocean International Center, 56 Mid 4th East Ring Rd, Chao Yang District, Beijing (hereinafter referred to as “GSK”); and
EXHIBIT 10.8 ------------ This is an Exhibit to the Form 20-F of Sinovac Biotech Ltd. ----------------------------------------------------------- Attached find the following materials: Pledge, Escrow and Indemnity Agreement entered into between the...Pledge, Escrow and Indemnity Agreement • May 27th, 2005 • Sinovac Biotech LTD • Pharmaceutical preparations • British Columbia
SUPPLEMENTAL AGREEMENT TO A LEASE CONTRACTSupplemental Agreement to a Lease Contract • April 30th, 2013 • Sinovac Biotech LTD • Pharmaceutical preparations
Lessor: China Bioway Biotech Group Co., Ltd. (hereinafter referred to as “Party A”) Legal Address: No. 39, Shangdi Xi Road, Haidian District, Beijing
EXHIBIT 10.7 ------------ This is an Exhibit to the Form 20-F of Sinovac Biotech Ltd. ----------------------------------------------------------- Attached find the following materials: Pledge, Escrow and Promissory Note Agreement entered into between...Pledge, Escrow and Promissory Note Agreement • May 27th, 2005 • Sinovac Biotech LTD • Pharmaceutical preparations • British Columbia
SINOVAC BIOTECH LTD. and PACIFIC STOCK TRANSFER COMPANY as Rights Agent FOURTH AMENDMENT TO AMENDED AND RESTATED RIGHTS AGREEMENT Effective as of February 21, 2023Rights Agreement • February 22nd, 2023 • Sinovac Biotech LTD • Pharmaceutical preparations • Delaware
This Fourth Amendment (this “Amendment”) to the Amended and Restated Rights Agreement (as defined below), is between Sinovac Biotech Ltd., an Antigua and Barbuda company (the “Company”), and Pacific Stock Transfer Company (the “Rights Agent”).
Lease ContractLease Contract • July 14th, 2006 • Sinovac Biotech LTD • Pharmaceutical preparations
Party A and Party B have reached agreement in respect of Party B’s renting of Party A’s Premises for business operation on the principle of equality and mutual benefit and on the basis of friendly negotiation and have entered into this Contract according to the Contract Law of the People’s Republic of China and other applicable laws and regulations of China.
SECOND AMENDMENT TO RIGHTS AGREEMENTRights Agreement • June 30th, 2017 • Sinovac Biotech LTD • Pharmaceutical preparations • Delaware
This Second Amendment (this “Amendment”), dated as of June 26, 2017, to the Rights Agreement, dated as of March 28, 2016 (the “Rights Agreement”), as amended on March 24, 2017, is between Sinovac Biotech Ltd., a company limited by shares under the laws of Antigua and Barbuda company (the “Company”), and Pacific Stock Transfer Company (the “Rights Agent”), and shall be effective immediately prior to the Company’s entry into that certain Amalgamation Agreement (as it may be amended from time to time, the “Amalgamation Agreement”) to be entered into by and among Sinovac (Cayman) Limited, an exempted limited liability company incorporated with limited liability under the laws of the Cayman Islands (“Parent”), Sinovac Amalgamation Sub Limited, an international business corporation incorporated under the laws of Antigua and Barbuda and a wholly-owned subsidiary of Parent, and the Company; provided, however, if (i) the Amalgamation Agreement is not executed as of even date herewith, or (ii) t
NON-DISCLOSURE, NON-COMPETITION AND PROPRIETARY INFORMATION AGREEMENTNon-Disclosure, Non-Competition and Proprietary Information Agreement • July 14th, 2006 • Sinovac Biotech LTD • Pharmaceutical preparations
In partial consideration and as a condition of my employment by Sinovac Biotech Co., Ltd. (“Company”), and effective as of the date that my employment by Company first commenced, I hereby agree as follows:
Lease ContractLease Contract • March 31st, 2008 • Sinovac Biotech LTD • Pharmaceutical preparations
Party A and Party B have reached agreement in respect of Party B’s renting of Party A’s Premises for business operation on the principles of equality and mutual benefit and on the basis of friendly negotiation and have entered into this Contract according to the Contract Law of the People’s Republic of China and other applicable laws and regulations of China.
Asset Acquisition Agreement In Relation to Guangda PharmaceuticalAsset Acquisition Agreement • April 16th, 2010 • Sinovac Biotech LTD • Pharmaceutical preparations
production and sales of human vaccine. Party B is also engaged in supporting the national reserve of pandemic influenza vaccines (H1N1 Influenza A). Party B intends to be assigned the Debtor’s aforesaid Real Estates, machinery and other assets that have been acquired by Party A through the judicial procedures for the purpose of production and storage of human vaccines.
TRUST AGREEMENTTrust Agreement • February 22nd, 2019 • Sinovac Biotech LTD • Pharmaceutical preparations • Delaware
TRUST AGREEMENT dated as of February 20, 2019 (this “Trust Agreement” or this “Agreement”) between Sinovac Biotech Ltd., as depositor (the “Depositor”), and Wilmington Trust, National Association, a national banking association, as trustee (the “Trustee”).
SINOVAC BIOTECH LTD. SHAREHOLDERS AGREEMENT Dated as of July 2, 2018Shareholders Agreement • July 3rd, 2018 • Sinovac Biotech LTD • Pharmaceutical preparations • New York
This Shareholders Agreement, dated as of July 2, 2018, by and among Sinovac Biotech Ltd. (the “Company”), and Vivo Capital, LLC (the “Lead Investor”) and Prime Success, L.P. (the “Co-Investor”, and together with the Lead Investor, each an “Investor” and collectively, the “Investors”).
SUPPLEMENTAL AGREEMENT TO A LEASE CONTRACTSupplemental Agreement to a Lease Contract • April 30th, 2013 • Sinovac Biotech LTD • Pharmaceutical preparations
Lessor: China Bioway Biotech Group Co., Ltd. (hereinafter referred to as “Party A”) Legal Address: No. 39, Shangdi Xi Road, Haidian District, Beijing
Equity Joint Venture Contract for the establishment of Sinovac (Dalian) Vaccine Technology Co., Ltd.Equity Joint Venture Contract • January 20th, 2010 • Sinovac Biotech LTD • Pharmaceutical preparations
Sinovac Biotech (Hong Kong) Ltd., a limited liability company duly incorporated and existing under the laws of Hong Kong Special Administrative Region of the People’s Republic of China (“PRC”) with its registration address at Room 1906, Lucky Commercial Centre, 103 Des Voeux Road West, Hong Kong (hereinafter referred to as Party A), and .
EXHIBIT 10.7 ------------ This is an Exhibit to the Form 20-F of Sinovac Biotech Ltd. ----------------------------------------------------------- Attached find the following materials: Consulting Services and Finder's Fee Agreement entered into...Consulting Services and Finder's Fee Agreement • June 30th, 2004 • Sinovac Biotech LTD • Pharmaceutical preparations • British Columbia
PACIFIC STOCK TRANSFER COMPANY as Rights Agent Rights Agreement Dated as of March 28, 2016Rights Agreement • March 29th, 2016 • Sinovac Biotech LTD • Pharmaceutical preparations • Delaware
Rights Agreement, dated as of March 28, 2016 (this “Agreement”), between SINOVAC BIOTECH LTD., an Antigua and Barbuda company (the “Company”), and Pacific Stock Transfer Company, as Rights Agent (the “Rights Agent”).
AMENDMENT NO. 2 TO THE AMALGAMATION AGREEMENTAmalgamation Agreement • April 27th, 2018 • Sinovac Biotech LTD • Pharmaceutical preparations
AMENDMENT NO. 2 TO AMALGAMATION AGREEMENT (this “Amendment”), dated as of April 26, 2018, among Sinovac (Cayman) Limited, an exempted company incorporated with limited liability under the laws of the Cayman Islands (“Parent”), Sinovac Amalgamation Sub Limited, an international business corporation incorporated under the laws of Antigua and Barbuda and a wholly-owned subsidiary of Parent (“Amalgamation Sub”), and Sinovac Biotech Ltd., a company limited by shares incorporated under the laws of Antigua and Barbuda (the “Company”). Parent, Amalgamation Sub and the Company may hereafter be referred to as a “Party” in their individual capacities and as “Parties” collectively.
AMENDMENT TO RIGHTS AGREEMENTRights Agreement • March 24th, 2017 • Sinovac Biotech LTD • Pharmaceutical preparations • Delaware
This Amendment (this “Amendment”), dated as of March 24, 2017 to the Rights Agreement, dated as of March 28, 2016 (the “Rights Agreement”), is between Sinovac Biotech Ltd., an Antigua and Barbuda company (the “Company”), and Pacific Stock Transfer Company (the “Rights Agent”).
Supplementary AgreementSupplementary Agreement • July 14th, 2006 • Sinovac Biotech LTD • Pharmaceutical preparations
Whereas Party A and Party B signed the Lease Contract on August 12, 2004 whereby Party A lets Workshop 2 and Section 3 of Research & Development Center in Peking University Biological Park, No. 39, Shangdi Xi Road, Haidian District, Beijing (hereinafter referred to as the “Property”) to Party B, the two parties have reached the following agreement on the advance payment of rent under the Lease Contract:
SINOVAC BIOTECH LTD. and PACIFIC STOCK TRANSFER COMPANY as Rights Agent SECOND AMENDMENT TO AMENDED AND RESTATED RIGHTS AGREEMENT Effective as of February 21, 2021Amended and Restated Rights Agreement • February 22nd, 2021 • Sinovac Biotech LTD • Pharmaceutical preparations • Delaware
This Second Amendment (this “Amendment”) to the Amended and Restated Rights Agreement (as defined below), is between Sinovac Biotech Ltd., an Antigua and Barbuda company (the “Company”), and Pacific Stock Transfer Company (the “Rights Agent”).
SHAREHOLDERS’ AGREEMENTShareholders Agreement • April 22nd, 2021 • Sinovac Biotech LTD • Pharmaceutical preparations
This Shareholders’ Agreement (this “Agreement”) is made and entered into by and among the following parties on December 4, 2020 (the “Execution Date”):
NET-FORCE SYSTEMS INC. Draft dated: [insert month here], [day], [year] SOFTWARE AND MARKETING LICENSE AGREEMENT Agreement dated oo. Between: Netforce Entertainment Inc. with registered offices at P.O. Box 1301, 60 Nevis St. St. John's, Antigua, W.I....Software and Marketing License Agreement • July 17th, 2002 • Net Force Systems Inc • Services-prepackaged software • St. John
